CA
NZ
UK
AU
IND
US
● Qiagen N.V is one of the quiet giants of molecular diagnostics, and its shares have been living up to a reputation for steadiness, trading around the low-$40s in September 2026 with little day-to-day drama.
A modest uptick in a rare-disease micro-cap can mask a company at a genuine inflection point. Quince Therapeutics, Inc (NASDAQ: QNCX) edged higher in its latest session, but the more important story sits in its pipeline: a late-stage program aimed at a devastating pediatric …
Rising Biosciences (OTC:RBII) sits at the far, speculative fringe of the U.S. micro-cap market, the kind of name that surfaces on stock screeners for its rock-bottomQuotationrather than for any headline development. The company leaves almost no verifiable public footprint.
Once promoted as a pioneer of spray-on skin-cell therapy, RenovaCare, Inc. (OTC:RCAR) has faded into the quietest corners of the market. The company's ambitious regenerative-medicine story ran headlong into regulatory scrutiny, litigation and a long stretch of silence.
For a company trading well under a dime, Vivos Inc (OTC:RDGL) has generated an outsized amount of regulatory news in 2026. The radiation-oncology micro-cap spent years developing an injectable radioactive gel it hopes can treat solid tumors, and this summer it cleared a milestone …
Regencell Bioscience Holdings (NASDAQ: RGC) has become one of the more talked-about names in the small-cap universe, and not primarily for its science. The Hong Kong-based traditional Chinese medicine developer has swung wildly over the past year, and its latest roughly 14% single-day drop …
● Rocket One is one of the more unusual names to surface on a health-and-technology screen, because the company investors once knew as a clinical-stage biopharmaceutical has reinvented itself as a space-and-defense computing venture.
When a stock trades for a small fraction of a penny, headline-grabbing percentage moves come easily - and RemSleep Holdings (OTC:RMSL) is a textbook case. The sleep-therapy device developer changes hands at sub-penny levels, so a shift of a tiny fraction of a cent …
A single-session bounce has put Pluri Inc (NASDAQ: PLUR) back on micro-cap radar screens. The cell-based technology company saw its shares tick higher in recent trading, settling near $1.37 with aMarket Valuein the mid-teens of millions of dollars. Yet the more relevant context is …
Insulet Corporation (NASDAQ: PODD) is one of the standout growth stories in diabetes technology, with its tubeless Omnipod system driving revenue up more than 20% a year. So when the shares turned lower in early September 2026, the move stood out against an otherwise …
Please wait processing your request...